Science
Mechanism of Action
The mechanism of action for Hypoxis Hemerocallidea Bulb Extract is multifaceted. Its antioxidant activity stems from phenolics and flavonoids, which scavenge free radicals. Hypoxoside, a prominent component, converts into rooperol, a potent antioxidant. Furthermore, phytosterols like beta-sitosterol are associated with immunomodulatory and anti-inflammatory effects, potentially supporting skin barrier function and mitigating inflammatory responses.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
Despite promising *in vitro* biological activities, this ingredient is not commonly 'dusted' given the significant gaps in regulatory safety assessments for topical use. Concerns regarding potential toxicity of isolated components and a lack of definitive human clinical data for cosmetic application warrant cautious and thorough evaluation, preventing its classification as an overhyped, under-researched ingredient.
The Formula
Formulation
Stability
The extract contains a blend of water-soluble compounds (e.g., phenolics, flavonoids) and poorly water-soluble components (e.g., sterols, hypoxoside precursors), suggesting its components can integrate into both aqueous and oil-based formulations depending on the extraction method. A dissolution study of hypoxoside explored stability across pH 1.2 to 7.5, but an optimal pH range for the stability of the entire extract in cosmetic formulations has not been specified.
Conflicts
- No specific cosmetic formulation incompatibilities have been identified. However, internal herb-drug interactions, particularly affecting cytochrome P450 (CYP) enzymes, have been noted, which might be a consideration for transdermal delivery or co-formulation with certain medications.
Safety
Safety Profile
Hypoxis Hemerocallidea Bulb Extract lacks specific safety assessments by regulatory bodies such as CIR, SCCS, or FDA for topical cosmetic use. While *in vitro* cytotoxicity studies provide LC50 values (e.g., 95.5-210.9 μg/ml), their direct translation to topical cosmetic safety remains undefined. Most studies confirming lack of toxicity are related to short and long-term *oral* use of the *plant extract* at high doses (e.g., 2.4 g/day). However, crude extracts are reportedly toxic, and isolated components like rooperol and hypoxoside have been linked to hepatorenal toxicity and bone marrow suppression. Beta-sitosterol, another component, has been used in OTC supplements for over 20 years, generally with minor oral side effects, but some rodent studies reported endocrine disruption, sterility in female rats, and altered sperm morphology in males. High oral doses (800 mg/kg) in diabetic rats have also shown abnormal kidney function. The absence of specific guidelines or quality control measures for traditional medicine use further complicates safety assessment for cosmetic applications.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Despite its promising *in vitro* antioxidant and anti-inflammatory activities, the lack of dedicated cosmetic safety assessments, coupled with reported toxicities of isolated components and insufficient data on topical efficacy and skin compatibility, renders this ingredient questionable for precision skincare formulations.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources